Barbara A Conley

Barbara A Conley

UNVERIFIED PROFILE

Are you Barbara A Conley?   Register this Author

Register author
Barbara A Conley

Barbara A Conley

Publications by authors named "Barbara A Conley"

Are you Barbara A Conley?   Register this Author

50Publications

1010Reads

10Profile Views

Defining, Identifying, and Understanding "Exceptional Responders" in Oncology Using the Tools of Precision Medicine.

Cancer J 2019 Jul/Aug;25(4):296-299

Early Clinical Trials Development Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0000000000000392DOI Listing
July 2019

Clinical Utility of Epstein-Barr Virus DNA Testing in the Treatment of Nasopharyngeal Carcinoma Patients.

Int J Radiat Oncol Biol Phys 2017 08 18;98(5):996-1001. Epub 2017 Mar 18.

Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2017.03.018DOI Listing
August 2017

Current State of PCR-Based Epstein-Barr Virus DNA Testing for Nasopharyngeal Cancer.

J Natl Cancer Inst 2017 04;109(4)

Cancer Diagnosis Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djx007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279258PMC
April 2017

Clinical Application of Liquid Biopsies.

JAMA Oncol 2016 Aug;2(8):1003-5

Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2016.0240DOI Listing
August 2016

Analytical Validation and Application of a Targeted Next-Generation Sequencing Mutation-Detection Assay for Use in Treatment Assignment in the NCI-MPACT Trial.

J Mol Diagn 2016 Jan 18;18(1):51-67. Epub 2015 Nov 18.

Molecular Characterization and Clinical Assay Development Laboratory, Leidos Biomedical Research Inc., and Frederick National Laboratory for Cancer Research, Frederick, Maryland; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmoldx.2015.07.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5812775PMC
January 2016

Next-Generation Sequencing to Guide Clinical Trials.

Clin Cancer Res 2015 Oct;21(20):4536-44

Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-3215DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4610034PMC
October 2015

AHNAK2 Participates in the Stress-Induced Nonclassical FGF1 Secretion Pathway.

J Cell Biochem 2015 Aug;116(8):1522-31

Center for Molecular Medicine, Maine Medical Center Research Institute, Maine Medical Center, Scarborough, 04074, Maine.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcb.25047DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697109PMC
August 2015

Genomically guided cancer treatments: from "promising" to "clinically useful".

Authors:
Barbara A Conley

J Natl Cancer Inst 2015 Jul 28;107(7). Epub 2015 May 28.

Division of Cancer Treatment and Diagnosism, National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services, 9609 Medical Center Drive Room 4W426 MSC 9730, Bethesda, MD, 20892

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv168DOI Listing
July 2015

Application of molecular profiling in clinical trials for advanced metastatic cancers.

J Natl Cancer Inst 2015 Apr 6;107(4). Epub 2015 Feb 6.

Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD (SK, ECP, APC, LVR, YZ, RMS, BAC, JHD); Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD (PMW, CJL).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334817PMC
April 2015

Molecular analysis for therapy choice: NCI MATCH.

Semin Oncol 2014 Jun 22;41(3):297-9. Epub 2014 May 22.

Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2014.05.002DOI Listing
June 2014

Statistical and practical considerations for clinical evaluation of predictive biomarkers.

J Natl Cancer Inst 2013 Nov 17;105(22):1677-83. Epub 2013 Oct 17.

Affiliations of authors: Biometric Research Branch (M-YCP, BF, ELK, LMS), Cancer Diagnosis Program (BAC), and Cancer Treatment and Evaluation Program (JSA), Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt282DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888208PMC
November 2013

Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration.

BMC Med 2013 Oct 17;11:220. Epub 2013 Oct 17.

Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Room 5W130, MSC 9735, 9609 Medical Center Drive, Bethesda, MD 20892-9735, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1741-7015-11-220DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3852338PMC
October 2013

Rare case of hairy cell leukemia with brain parenchymal involvement: a diagnostic dilemma.

J Clin Oncol 2013 Apr 25;31(11):e186-8. Epub 2013 Feb 25.

Division of Hematology and Oncology, West Michigan Cancer Center, 200 N Park St, Kalamazoo, MI 49007, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2012.44.8787DOI Listing
April 2013

Endoglin regulates cancer-stromal cell interactions in prostate tumors.

Cancer Res 2011 May 28;71(10):3482-93. Epub 2011 Mar 28.

Center for Molecular Medicine, Maine Medical Center Research Institute, Scarborough, Maine 04074, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-10-2665DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3096740PMC
May 2011

Unusual presentation of large-cell poorly differentiated neuroendocrine carcinoma of the epiglottis.

J Clin Oncol 2010 Sep 2;28(27):e461-3. Epub 2010 Aug 2.

Michigan State University, East Lansing, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.28.6237DOI Listing
September 2010

Endoglin phosphorylation by ALK2 contributes to the regulation of prostate cancer cell migration.

Carcinogenesis 2010 Mar 7;31(3):359-66. Epub 2009 Sep 7.

Center for Molecular Medicine, Maine Medical Center Research Institute, Scarborough, ME 04074, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgp217DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2832542PMC
March 2010

Neoadjuvant chemotherapy for locally advanced squamous cancers of the head and neck: current status and future prospects.

Curr Opin Oncol 2009 May;21(3):218-23

Division of Hematology/Oncology, Department of Medicine, College of Human Medicine, Michigan State University, East Lansing, Michigan 48824, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/cco.0b013e328329abe5DOI Listing
May 2009

Histone deacetylation : an attractive target for cancer therapy?

Drugs R D 2008 ;9(6):369-83

Department of Medicine, College of Human Medicine, Michigan State University, East Lansing, Michigan, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/0126839-200809060-00003DOI Listing
February 2009

Salivary gland cancers: current treatments, molecular characteristics and new therapies.

Expert Rev Anticancer Ther 2008 Apr;8(4):645-52

Division of Hematology/Oncology, Michigan State University, Breslin Cancer Center 401, W. Greenlawn Avenue, Lansing, MI, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.8.4.645DOI Listing
April 2008

Novel biochemical pathways of endoglin in vascular cell physiology.

J Cell Biochem 2007 Dec;102(6):1375-88

Centro de Investigaciones Biologicas, Consejo Superior de Investigaciones Cientificas (CSIC), 28040 Madrid, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcb.21594DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2199238PMC
December 2007

Endoglin is required for myogenic differentiation potential of neural crest stem cells.

Dev Biol 2007 Aug 16;308(2):520-33. Epub 2007 Jun 16.

Center for Molecular Medicine, Maine Medical Center Research Institute, 81 Research Drive, Scarborough, ME 04074, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ydbio.2007.06.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2041841PMC
August 2007

Endoglin structure and function: Determinants of endoglin phosphorylation by transforming growth factor-beta receptors.

J Biol Chem 2006 Sep 19;281(35):25110-23. Epub 2006 Jun 19.

Center for Molecular Medicine, Maine Medical Center Research Institute, Scarborough, Maine 04074, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M601288200DOI Listing
September 2006

Targeting epigenetic abnormalities with histone deacetylase inhibitors.

Cancer 2006 Aug;107(4):832-40

Division of Hematology/Oncology, Department of Medicine, College of Human Medicine, B414 Clinical Center, Michigan State University, East Lansing, Michigan 48824, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.22064DOI Listing
August 2006

Treatment of advanced head and neck cancer: what lessons have we learned?

Authors:
Barbara A Conley

J Clin Oncol 2006 Mar;24(7):1023-5

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.05.0682DOI Listing
March 2006

Interspecies differences in plasma protein binding of MS-275, a novel histone deacetylase inhibitor.

Cancer Chemother Pharmacol 2006 Feb 19;57(3):275-81. Epub 2005 Jul 19.

Clinical Pharmacology Research Core, National Cancer Institute, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-005-0058-8DOI Listing
February 2006

Clinical trial designs for predictive marker validation in cancer treatment trials.

J Clin Oncol 2005 Mar;23(9):2020-7

Mayo Clinic, Kahler 1A, 200 First St, SW, Rochester, MN 55905, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.01.112DOI Listing
March 2005

Prognostic and predictive markers in cancer.

Dis Markers 2004 ;20(2):35-43

Medical Oncology Clinical Research Unit, Center for Cancer Research, NCI, NIH, DHHS, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839402PMC
http://dx.doi.org/10.1155/2004/202031DOI Listing
February 2005

Vascular injury induces expression of periostin: implications for vascular cell differentiation and migration.

Arterioscler Thromb Vasc Biol 2005 Jan 28;25(1):77-83. Epub 2004 Oct 28.

Center for Molecular Medicine, Maine Medical Center Research Institute, Scarborough, ME 04074, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/01.ATV.0000149141.81230.c6DOI Listing
January 2005

Endoglin controls cell migration and composition of focal adhesions: function of the cytosolic domain.

J Biol Chem 2004 Jun 14;279(26):27440-9. Epub 2004 Apr 14.

Center for Molecular Medicine, Maine Medical Center Research Institute, Scarborough, Maine 04074, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1074/jbc.M312561200DOI Listing
June 2004

Detection of prostate cancer and predicting progression: current and future diagnostic markers.

Clin Cancer Res 2004 Jun;10(12 Pt 1):3943-53

Diagnostics Research Branch, Cancer Diagnosis Program, National Cancer Institute, Rockville, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-03-0200DOI Listing
June 2004

Clinical trials referral resource. Targeted therapy in squamous cell cancers of the head and neck.

Oncology (Williston Park) 2002 May;16(5):621-2, 625-6

National Cancer Institute, USA.

View Article

Download full-text PDF

Source
May 2002